Fund profile
Tickers
HRTS
Fund manager
Total assets
$49.17 mm
Liabilities
$1.28 mm
Net assets
$47.90 mm
Number of holdings
43.00
HRTS stock data
43 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 2.35 mm | 3.12 k shares | 4.92 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 2.32 mm | 5.51 k shares | 4.84 | Common equity | Long | USA |
Novo Nordisk A/S
|
2.21 mm | 18.60 k shares | 4.62 | Common equity | Long | Denmark |
AMGN AMGEN Inc. | 1.99 mm | 7.26 k shares | 4.15 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 1.65 mm | 21.47 k shares | 3.45 | Common equity | Long | USA |
DXCM Dexcom Inc | 1.63 mm | 14.19 k shares | 3.41 | Common equity | Long | USA |
Chugai Pharmaceutical Co Ltd
|
1.48 mm | 37.06 k shares | 3.10 | Common equity | Long | Japan |
MREO Mereo Biopharma Group Plc | 1.41 mm | 371.47 k shares | 2.95 | Common equity | Long | UK |
RCKT Rocket Pharmaceuticals Inc | 1.33 mm | 45.44 k shares | 2.78 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 1.33 mm | 18.41 k shares | 2.78 | Common equity | Long | USA |
MDT Medtronic Plc | 1.33 mm | 15.90 k shares | 2.77 | Common equity | Long | Ireland |
ASND Ascendis Pharma A/S | 1.30 mm | 8.80 k shares | 2.72 | Common equity | Long | Denmark |
RARE Ultragenyx Pharmaceutical Inc. | 1.30 mm | 25.13 k shares | 2.71 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 1.28 mm | 31.38 k shares | 2.68 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 1.28 mm | 15.05 k shares | 2.67 | Common equity | Long | USA |
PODD Insulet Corporation | 1.26 mm | 7.67 k shares | 2.63 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 1.25 mm | 38.77 k shares | 2.60 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 1.15 mm | 7.60 k shares | 2.40 | Common equity | Long | USA |
Novartis AG
|
1.14 mm | 11.22 k shares | 2.37 | Common equity | Long | Switzerland |
BMY Bristol-Myers Squibb Co. | 1.12 mm | 22.09 k shares | 2.34 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 1.11 mm | 32.57 k shares | 2.32 | Common equity | Long | USA |
Zealand Pharma A/S
|
1.10 mm | 11.40 k shares | 2.29 | Common equity | Long | Denmark |
BSX Boston Scientific Corp. | 1.09 mm | 16.47 k shares | 2.28 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 1.04 mm | 4.40 k shares | 2.17 | Common equity | Long | USA |
ABMD Abiomed Inc | 963.13 k | 3.69 k shares | 2.01 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 937.29 k | 20.73 k shares | 1.96 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 905.58 k | 2.53 k shares | 1.89 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 902.09 k | 28.02 k shares | 1.88 | Common equity | Long | USA |
MASI Masimo Corp | 894.38 k | 6.96 k shares | 1.87 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 875.17 k | 27.26 k shares | 1.83 | Common equity | Long | USA |
TNYA Tenaya Therapeutics Inc | 860.95 k | 144.70 k shares | 1.80 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 858.30 k | 55.81 k shares | 1.79 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 671.48 k | 24.88 k shares | 1.40 | Common equity | Long | USA |
OSCR Oscar Health Inc - Ordinary Shares | 658.48 k | 40.50 k shares | 1.37 | Common equity | Long | USA |
NARI Inari Medical Inc | 654.90 k | 14.20 k shares | 1.37 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 643.21 k | 9.53 k shares | 1.34 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 547.19 k | 32.09 k shares | 1.14 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 541.71 k | 13.98 k shares | 1.13 | Common equity | Long | USA |
OMCL Omnicell, Inc. | 529.10 k | 20.16 k shares | 1.10 | Common equity | Long | USA |
First American Treasury Obligations Fund | 502.80 k | 502.80 k shares | 1.05 | Short-term investment vehicle | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 497.37 k | 17.32 k shares | 1.04 | Common equity | Long | USA |
Bayer AG
|
418.30 k | 13.78 k shares | 0.87 | Common equity | Long | Germany |
GPCR Structure Therapeutics Inc | 318.84 k | 7.86 k shares | 0.67 | Common equity | Long | USA |